Microgravity experiments on the International Space Station helped Merck develop a faster subcutaneous version of Keytruda ...

Moorfields hospital in London is the world's first dedicated clinic for the disorder and seven out of eight patients given ...

Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable responses were ...

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...

Glucocorticoid injections into the infrapatellar fat pad do not reduce knee pain or effusion synovitis volume in patients ...